Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
OXALIPLATIN
(2002)
Small molecule
DNA inhibitor
INJECTION; INTRAVENOUS
Approved
Unknown
OXALIPLATIN
×
Maximum Phase:
4
First Approval:
2002
UNII:
04ZR38536J
Molecule Type:
Small molecule
Molecular Formula:
C8H12N2O4Pt
Molecular Weight:
395.27
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VORICONAZOLE
(2002)
Small molecule
Cytochrome P450 51 inhibitor
INJECTION; INTRAVENOUS; IV (INFUSION); ORAL
Approved
Aspergillosis; Candidemia; Candidiasis; Fusariosis; Infections
VORICONAZOLE
×
Maximum Phase:
4
First Approval:
2002
UNII:
JFU09I87TR
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3N5O
Molecular Weight:
349.32
AlogP:
2.18
PSA:
76.72
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OXAPROZIN POTASSIUM
(2002)
Small molecule
Cyclooxygenase inhibitor
ORAL
Approved
Unknown
OXAPROZIN POTASSIUM
×
Maximum Phase:
4
First Approval:
2002
UNII:
ML56O2Z92I
Molecule Type:
Small molecule
Molecular Formula:
C18H14KNO3
Molecular Weight:
331.41
AlogP:
4.03
PSA:
63.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ELETRIPTAN
(2002)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
ELETRIPTAN
×
Maximum Phase:
4
First Approval:
2002
UNII:
22QOO9B8KI
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2S
Molecular Weight:
382.53
AlogP:
3.82
PSA:
53.17
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ESCITALOPRAM
(2002)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
ESCITALOPRAM
×
Maximum Phase:
4
First Approval:
2002
UNII:
4O4S742ANY
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN2O
Molecular Weight:
324.4
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PERFLEXANE
(2002)
Small molecule
Unknown
Unknown
Approved
Unknown
PERFLEXANE
×
Maximum Phase:
4
First Approval:
2002
UNII:
FX3WJ41CMX
Molecule Type:
Small molecule
Molecular Formula:
C6F14
Molecular Weight:
338.04
AlogP:
4.65
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ZIPRASIDONE MESYLATE
(2002)
Small molecule
Dopamine D2 receptor antagonist
INTRAMUSCULAR
Approved
Bipolar Disorder
ZIPRASIDONE MESYLATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
3X6SAX83JZ
Molecule Type:
Small molecule
Molecular Formula:
C22H31ClN4O7S2
Molecular Weight:
563.1
AlogP:
3.81
PSA:
48.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GUAIFENESIN
(2002)
Small molecule
Unknown
ORAL
Approved
Cough; Fever; Headache; Sinusitis
GUAIFENESIN
×
Maximum Phase:
4
First Approval:
2002
UNII:
495W7451VQ
Molecule Type:
Small molecule
Molecular Formula:
C10H14O4
Molecular Weight:
198.22
AlogP:
0.43
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EZETIMIBE
(2002)
Small molecule
Niemann-Pick C1-like protein 1 inhibitor
ORAL
Approved
Cardiovascular Diseases; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II
EZETIMIBE
×
Maximum Phase:
4
First Approval:
2002
UNII:
EOR26LQQ24
Molecule Type:
Small molecule
Molecular Formula:
C24H21F2NO3
Molecular Weight:
409.43
AlogP:
4.89
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ATOMOXETINE
(2002)
Small molecule
Unknown
Unknown
Approved
Attention Deficit Disorder with Hyperactivity
ATOMOXETINE
×
Maximum Phase:
4
First Approval:
2002
UNII:
ASW034S0B8
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO
Molecular Weight:
255.36
AlogP:
3.72
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ARIPIPRAZOLE
(2002)
Small molecule
Dopamine D2 receptor partial agonist
INTRAMUSCULAR; ORAL; ORALLY DISINTEGRATING
Approved
Aggression; Autistic Disorder; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Psychomotor Agitation; Psychotic Disorders; Schizophrenia
ARIPIPRAZOLE
×
Maximum Phase:
4
First Approval:
2002
UNII:
82VFR53I78
Molecule Type:
Small molecule
Molecular Formula:
C23H27Cl2N3O2
Molecular Weight:
448.39
AlogP:
4.86
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
7.0
Source:
OLMESARTAN MEDOXOMIL
(2002)
Small molecule
Type-1 angiotensin II receptor antagonist
Unknown
Approved
Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
OLMESARTAN MEDOXOMIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
6M97XTV3HD
Molecule Type:
Small molecule
Molecular Formula:
C29H30N6O6
Molecular Weight:
558.6
AlogP:
4.17
PSA:
162.16
HBD:
2.0
HBA:
#RotB:
10.0
Source:
FULVESTRANT
(2002)
Small molecule
Estrogen receptor antagonist
INTRAMUSCULAR
Approved
Breast Neoplasms; Neoplasms
FULVESTRANT
×
Maximum Phase:
4
First Approval:
2002
UNII:
22X328QOC4
Molecule Type:
Small molecule
Molecular Formula:
C32H47F5O3S
Molecular Weight:
606.78
AlogP:
8.68
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
OXYBATE
(2002)
Small molecule
Unknown
Unknown
Approved
Unknown
OXYBATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
30IW36W5B2
Molecule Type:
Small molecule
Molecular Formula:
C4H8O3
Molecular Weight:
104.11
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TEGASEROD
(2002)
Small molecule
Unknown
Unknown
Approved
Constipation
TEGASEROD
×
Maximum Phase:
4
First Approval:
2002
UNII:
458VC51857
Molecule Type:
Small molecule
Molecular Formula:
C16H23N5O
Molecular Weight:
301.39
AlogP:
2.81
PSA:
85.29
HBD:
4.0
HBA:
#RotB:
7.0
Source:
TEGASEROD MALEATE
(2002)
Small molecule
Serotonin 4 (5-HT4) receptor partial agonist
ORAL
Approved
Constipation; Irritable Bowel Syndrome
TEGASEROD MALEATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
E5XNT3RF5A
Molecule Type:
Small molecule
Molecular Formula:
C20H27N5O5
Molecular Weight:
417.47
AlogP:
2.81
PSA:
85.29
HBD:
4.0
HBA:
#RotB:
7.0
Source:
EPLERENONE
(2002)
Small molecule
Mineralocorticoid receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Stroke
EPLERENONE
×
Maximum Phase:
4
First Approval:
2002
UNII:
6995V82D0B
Molecule Type:
Small molecule
Molecular Formula:
C24H30O6
Molecular Weight:
414.5
AlogP:
3.12
PSA:
82.2
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESCITALOPRAM OXALATE
(2002)
Small molecule
Serotonin transporter inhibitor
ORAL
Approved
Anxiety; Anxiety Disorders; Depression; Depressive Disorder, Major
ESCITALOPRAM OXALATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
5U85DBW7LO
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN2O5
Molecular Weight:
414.43
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ELETRIPTAN HYDROBROMIDE
(2002)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
ELETRIPTAN HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
M41W832TA3
Molecule Type:
Small molecule
Molecular Formula:
C22H27BrN2O2S
Molecular Weight:
463.44
AlogP:
3.82
PSA:
53.17
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ATOMOXETINE HYDROCHLORIDE
(2002)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
ATOMOXETINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
57WVB6I2W0
Molecule Type:
Small molecule
Molecular Formula:
C17H22ClNO
Molecular Weight:
291.82
AlogP:
3.72
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
HYDROQUINONE
(2002)
Small molecule
Unknown
Unknown
Approved
Hyperpigmentation; Lentigo; Melanosis
HYDROQUINONE
×
Maximum Phase:
4
First Approval:
2002
UNII:
XV74C1N1AE
Molecule Type:
Small molecule
Molecular Formula:
C6H6O2
Molecular Weight:
110.11
AlogP:
1.1
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
NITAZOXANIDE
(2002)
Small molecule
Pyruvate:ferredoxin oxidoreductase inhibitor
ORAL
Approved
Diarrhea
NITAZOXANIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
SOA12P041N
Molecule Type:
Small molecule
Molecular Formula:
C12H9N3O5S
Molecular Weight:
307.29
AlogP:
2.23
PSA:
111.43
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ADEFOVIR DIPIVOXIL
(2002)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
ORAL
Approved
Hepatitis B, Chronic; Virus Diseases
ADEFOVIR DIPIVOXIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
U6Q8Z01514
Molecule Type:
Small molecule
Molecular Formula:
C20H32N5O8P
Molecular Weight:
501.48
AlogP:
2.7
PSA:
166.98
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SODIUM OXYBATE
(2002)
Small molecule
GABA-B receptor agonist
ORAL
Approved
Narcolepsy
SODIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
7G33012534
Molecule Type:
Small molecule
Molecular Formula:
C4H7NaO3
Molecular Weight:
126.09
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TREPROSTINIL
(2002)
Small molecule
Prostanoid IP receptor agonist
INHALATION; INTRAVENOUS; IV (INFUSION); SUBCUTANEOUS
Approved
Hypertension, Pulmonary; Pulmonary Arterial Hypertension; Thrombosis
TREPROSTINIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
RUM6K67ESG
Molecule Type:
Small molecule
Molecular Formula:
C23H34O5
Molecular Weight:
390.52
AlogP:
3.58
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
NITISINONE
(2002)
Small molecule
4-hydroxyphenylpyruvate dioxygenase inhibitor
ORAL
Approved
Unknown
NITISINONE
×
Maximum Phase:
4
First Approval:
2002
UNII:
K5BN214699
Molecule Type:
Small molecule
Molecular Formula:
C14H10F3NO5
Molecular Weight:
329.23
AlogP:
2.73
PSA:
94.35
HBD:
0.0
HBA:
#RotB:
3.0
Source:
FOSAMPRENAVIR CALCIUM
(2003)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections
FOSAMPRENAVIR CALCIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
ID1GU2627N
Molecule Type:
Small molecule
Molecular Formula:
C25H34CaN3O9PS
Molecular Weight:
623.68
AlogP:
2.52
PSA:
177.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
PALONOSETRON HYDROCHLORIDE
(2003)
Small molecule
Serotonin 3a (5-HT3a) receptor antagonist
INJECTION; INTRAVENOUS; ORAL
Approved
Nausea; Neoplasms; Postoperative Nausea and Vomiting; Vomiting
PALONOSETRON HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
23310D4I19
Molecule Type:
Small molecule
Molecular Formula:
C19H25ClN2O
Molecular Weight:
332.88
AlogP:
2.66
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
1.0
Source:
PAROXETINE MESYLATE
(2003)
Small molecule
Serotonin transporter inhibitor
ORAL
Approved
Unknown
PAROXETINE MESYLATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
M711N184JE
Molecule Type:
Small molecule
Molecular Formula:
C20H24FNO6S
Molecular Weight:
425.48
AlogP:
3.33
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EPINASTINE HYDROCHLORIDE
(2003)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Conjunctivitis, Allergic
EPINASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
GFM415S5XL
Molecule Type:
Small molecule
Molecular Formula:
C16H16ClN3
Molecular Weight:
285.78
AlogP:
2.47
PSA:
41.62
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CARBINOXAMINE MALEATE
(2003)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Angioedema; Conjunctivitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor; Urticaria
CARBINOXAMINE MALEATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
02O55696WH
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN2O5
Molecular Weight:
406.87
AlogP:
3.4
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AMLODIPINE MALEATE
(2003)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Unknown
AMLODIPINE MALEATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
CQ27G2BZJM
Molecule Type:
Small molecule
Molecular Formula:
C24H29ClN2O9
Molecular Weight:
524.95
AlogP:
2.27
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IBANDRONIC ACID
(2003)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
IBANDRONIC ACID
×
Maximum Phase:
4
First Approval:
2003
UNII:
UMD7G2653W
Molecule Type:
Small molecule
Molecular Formula:
C9H23NO7P2
Molecular Weight:
319.23
AlogP:
0.5
PSA:
138.53
HBD:
5.0
HBA:
#RotB:
9.0
Source:
TADALAFIL
(2003)
Small molecule
Phosphodiesterase 5A inhibitor
ORAL
Approved
Erectile Dysfunction; Hypertension, Pulmonary; Prostatic Hyperplasia; Pulmonary Arterial Hypertension
TADALAFIL
×
Maximum Phase:
4
First Approval:
2003
UNII:
742SXX0ICT
Molecule Type:
Small molecule
Molecular Formula:
C22H19N3O4
Molecular Weight:
389.41
AlogP:
2.21
PSA:
74.87
HBD:
1.0
HBA:
#RotB:
1.0
Source:
APREPITANT
(2003)
Small molecule
Neurokinin 1 receptor antagonist
INTRAVENOUS; ORAL
Approved
Nausea; Neoplasms; Postoperative Nausea and Vomiting
APREPITANT
×
Maximum Phase:
4
First Approval:
2003
UNII:
1NF15YR6UY
Molecule Type:
Small molecule
Molecular Formula:
C23H21F7N4O3
Molecular Weight:
534.43
AlogP:
4.95
PSA:
83.24
HBD:
2.0
HBA:
#RotB:
6.0
Source:
GEMIFLOXACIN
(2003)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
GEMIFLOXACIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
OKR68Y0E4T
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O4
Molecular Weight:
389.39
AlogP:
0.97
PSA:
123.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
52
53
54
55
56
57
58
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA